Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLC.

Saved in:
Bibliographic Details
Title: Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLC.
Authors: Mascaux C; Department of Pulmonology, University Hospital of Strasbourg, Strasbourg, France; Institut National De La Santé et De La Recherche Médicale (INSERM), Unité Mixte de Recherche (UMR)_1260, Regenerative Nanomedicine (NanoRegMed), Strasbourg University, Strasbourg, France., Sen T; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Sanchez-Cespedes M; Cancer Genetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain., Ortiz-Cuaran S; Univ Lyon, Claude Bernard Lyon 1 University, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France., Bossé Y; Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Quebec City, Quebec, Canada; Department of Molecular Medicine, Université Laval, Quebec City, Quebec, Canada., Dammeijer F; Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands., Cavic M; Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Barr MP; Thoracic Oncology Research Group, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland; Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland., Arulananda S; Department of Medical Oncology, Monash Health, Clayton, Australia., Armisen R; Centro de Genética y Genómica, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile., Berger AH; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington., Bianchi F; Unit of Cancer Biomarkers, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Carbone DP; Department of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; Pelotonia Institute for Immuno-Oncology, Columbus, Ohio., Cerciello F; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Lockwood WW; Department of Integrative Oncology, British Columbia Cancer Research Institute, Vancouver, British Columbia, Canada., Mitsudomi T; Izumi City General Hospital, Izumi, Japan; Division of Thoracic Surgery, Department of Surgery, Kindai University, Osaka, Japan., Ohara S; Division of Thoracic Surgery, Department of Surgery, Kindai University, Osaka, Japan., Politi K; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Qin S; Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China., Roisman LC; Cancer Research Institute, Samson Assuta Hospital, Ashdod, Israel; Faculty of Health Sciences - Microbiology and Immunology, Ben Gurion University, Beer Sheva, Israel., Samstein R; Department of Radiation Oncology, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, New York., Skoulidis F; Department of Thoracic Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tan AC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Thomas A; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Zhang J; Department of Thoracic Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wynes MW; International Association for the Study of Lung Cancer, Denver, Colorado., John T; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Tsao MS; University Health Network-Princess Margaret Cancer Centre, Toronto, Canada; Department of Laboratory Medicine, Department of Medical Biophysics, University of Toronto, Toronto, Canada. Electronic address: ming.tsao@uhn.ca.
Corporate Authors: IASLC Basic and Translational Science Committee
Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2025 Oct; Vol. 20 (10), pp. 1369-1391. Date of Electronic Publication: 2025 Jun 03.
Publication Type: Journal Article; Review; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1556-1380
DOI:10.1016/j.jtho.2025.05.024